These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6834385)

  • 1. 4-(Diphenylmethyl)-1-[(imino)methyl]piperidines as gastric antisecretory agents.
    Scott MK; Jacoby HI; Mills JE; Bonfilio AC; Rasmussen CR
    J Med Chem; 1983 Apr; 26(4):535-8. PubMed ID: 6834385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisecretory activity of fenoctimine in rat and dog.
    Jacoby HI; Bonfilio AC; Corcoran T; Lopez I; Scott M
    Dig Dis Sci; 1984 Dec; 29(12):1131-6. PubMed ID: 6499632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisecretory activity of human, dog, and rat metabolites of fenoctimine.
    Scott MK; Jacoby HI; Bonfilio AC; Corcoran TW; Lopez IS
    J Med Chem; 1987 May; 30(5):894-9. PubMed ID: 3572978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiulcer agents. II. Synthesis and gastric acid antisecretory activity of N-[3-(3-(piperidinomethyl)phenoxy)propyl]-4-(1-methyl-1H- tetrazol-5-ylthio)butanamide and related compounds.
    Ueda I; Ishii K; Sinozaki K; Seiki M; Hatanaka M
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1430-5. PubMed ID: 1934163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and identification of the metabolites of fenoctimine using in vitro drug metabolizing systems.
    McKown LA; Wu WN; O'Neill PJ
    J Pharm Biomed Anal; 1994 Jun; 12(6):771-5. PubMed ID: 7918779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the long acting gastric antisecretory activity of LM 24056 a non H2 antagonist.
    Mizoule J; Rataud J; Le Fur G; Jozefczak C; Quarteronet D; Uzan A
    Life Sci; 1982 Oct; 31(14):1473-85. PubMed ID: 7144436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of nitric oxide synthase through muscarinic receptors in rat parotid gland.
    Rosignoli F; Pérez Leirós C
    Eur J Pharmacol; 2002 Mar; 439(1-3):27-33. PubMed ID: 11937089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
    Gao ZG; Liu CG
    Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative anticholinergic properties of thioridazine, mesoridazine and sulforidazine.
    Niedzwiecki DM; Cubeddu LX; Mailman RB
    J Pharmacol Exp Ther; 1989 Jul; 250(1):126-33. PubMed ID: 2746492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic receptors in rat uterus.
    Pennefather JN; Gillman TA; Mitchelson F
    Eur J Pharmacol; 1994 Sep; 262(3):297-300. PubMed ID: 7813596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to activation of phospholipase C by carbachol in rat brain cortical membranes.
    Sallés J; Wallace MA; Fain JN
    J Pharmacol Exp Ther; 1993 Feb; 264(2):521-9. PubMed ID: 8437104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport.
    Zimmerman TW; Binder HJ
    Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New classes of antimuscarinic agents endowed with selective antispasmodic properties. 1-Arylsulfonyl pyrrolidin-2-ones and 2-thiones, 1-arylsulfonyl piperidin-2-ones and 2-thiones and 1-arylsulfonyl hexahydro-2H-azepin-2-one.
    Toja E; Parini C; Bonetti C; Hunt P; Fortin M; Barzaghi F; Cesana R; Maggioni A; Nencioni A; Galliani G
    Arzneimittelforschung; 1994 Apr; 44(4):501-9. PubMed ID: 8011004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MI cholinergic receptors of gastric secretion: current status].
    Vatier J
    J Pharmacol; 1985; 16 Suppl 2():145-69. PubMed ID: 2867250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the gastric (H+ + K+)-ATPase by fenoctimine.
    Reenstra WW; Shortridge B; Forte JG
    Biochem Pharmacol; 1985 Jul; 34(13):2331-4. PubMed ID: 2990481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of muscarinic receptor subtypes on rat pancreatic acini: pharmacological identification by secretory responses and binding studies.
    Kato M; Ohkuma S; Kataoka K; Kashima K; Kuriyama K
    Digestion; 1992; 52(3-4):194-203. PubMed ID: 1281128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antiulcer activity of 5,11-dihydro[1]benzoxepino[3,4-b]pyridines.
    Kumazawa T; Harakawa H; Obase H; Oiji Y; Tanaka H; Shuto K; Ishii A; Oka T; Nakamizo N
    J Med Chem; 1988 Apr; 31(4):779-85. PubMed ID: 3351856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the muscarinic receptor binding activity of some tertiary amines and their quaternary ammonium analogues.
    Ehlert FJ; Jenden DJ
    Mol Pharmacol; 1984 Jan; 25(1):46-50. PubMed ID: 6708935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic receptor subtype selectivity of novel heterocyclic QNB analogues.
    Baumgold J; Cohen VI; Paek R; Reba RC
    Life Sci; 1991; 48(24):2325-9. PubMed ID: 2046461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
    Makovec F; Revel L; Letari O; Mennuni L; Impicciatore M
    Eur J Pharmacol; 1999 Mar; 369(1):81-90. PubMed ID: 10204685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.